Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $34.45B | $4.97B | $318.03M | $68.55M | $0.05 | 49.92% | 79.66% | N/A | N/A | |||
| CORT | CORCEPT THERAPEUTICS INC | $4.02B | $741.17M | $65.98M | $104.65M | $1.00 | 17.92% | 15.79% | -26.47% | 1.03% | 2026-02-18 | ||
| NVO | NOVO NORDISK A S | $232.79B | $48.63B | $24.81B | $15.99B | $3.60 | 24.34% | 20.08% | 17.10% | 21.36% | 2026-02-04 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $52.87B | $3.21B | $151.92M | $43.57M | $0.31 | 53.24% | 51.59% | N/A | N/A | 2026-02-12 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.18B | $597.97M | $53.58M | $35.92M | $0.49 | 55.68% | N/A | N/A | N/A | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $469.52M | $84.39M | $67.21M | $35.33M | $0.48 | 244.60% | 46.99% | N/A | N/A | |||
| VCEL | VERICEL CORP | $1.80B | $258.72M | $29.31M | $13.08M | $0.26 | 14.05% | 16.93% | 271.43% | 67.03% | 2026-02-26 | ||
| ARGX | ARGENX SE | $51.27B | $1.92M | $811.30M | $1.51B | $25.02 | -94.62% | -50.87% | N/A | N/A | 2026-02-26 | ||
| KRYS | KRYSTAL BIOTECH INC | $7.16B | $373.16M | $193.29M | $198.91M | $6.90 | 54.51% | N/A | 275.00% | N/A | 2026-03-02 | ||
| GMAB | GENMAB A | $20.43B | $3.56B | $2.00B | $1.47B | $2.34 | 21.61% | 18.35% | 116.79% | 14.02% | 2026-02-05 | ||
| TECH | BIO-TECHNE CORP | $9.29B | $1.22B | $220.90M | $77.99M | $0.50 | 3.85% | 9.88% | -47.37% | -20.99% | 2026-02-03 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $3.74B | $251.23M | $103.01M | $48.58M | $2.31 | 64.83% | 11.86% | -12.50% | 80.67% | 2026-03-04 | ||
| ADMA | ADMA BIOLOGICS INC | $4.26B | $488.56M | $172.13M | $209.45M | $0.88 | 27.62% | 64.71% | 203.45% | N/A | |||
| ABEO | ABEONA THERAPEUTICS INC | $287.76M | $400.00k | $89.85M | $82.35M | $1.59 | N/A | -43.59% | N/A | N/A | |||
| MNKD | MANNKIND CORP | $1.72B | $313.79M | $73.18M | $29.23M | $0.10 | 17.44% | 38.00% | 25.00% | N/A | 2026-03-03 | ||
| VCYT | VERACYTE INC | $3.35B | $495.14M | $57.00M | $30.32M | $0.39 | 16.41% | 34.46% | N/A | N/A | 2026-03-02 | ||
| RPRX | ROYALTY PHARMA PLC | $22.43B | $2.35B | $1.04B | $764.96M | $1.76 | 3.70% | 3.20% | -31.52% | N/A | 2026-02-10 | ||
| CRMD | CORMEDIX INC | $958.07M | $214.30M | $112.26M | $162.50M | $2.27 | 1,647.67% | 300.38% | N/A | N/A | |||
| NAGE | NIAGEN BIOSCIENCE INC | $498.79M | $124.71M | $22.69M | $20.43M | $0.27 | 36.04% | 16.99% | 2,600.00% | N/A | |||
| EXEL | EXELIXIS INC | $11.68B | $2.29B | $927.60M | $677.90M | $2.46 | 9.93% | 19.03% | 55.70% | 37.53% | 2026-02-10 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $114.71B | $11.72B | $4.66B | $3.68B | $14.31 | 10.33% | 14.37% | N/A | 6.67% | 2026-02-04 | ||
| HALO | HALOZYME THERAPEUTICS INC | $8.27B | $1.24B | $845.48M | $595.49M | $4.89 | 31.19% | 44.17% | 59.28% | 93.56% | 2026-02-24 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $139.93M | $61.84M | $8.87M | $5.39M | $0.07 | 35.42% | 0.22% | N/A | N/A | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.42B | $3.09B | $772.70M | $520.42M | $2.72 | 12.39% | 10.68% | 60.00% | -10.40% | 2026-02-25 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $3.27B | $1.02B | $93.37M | $44.99M | $0.35 | 42.11% | 335.88% | N/A | N/A | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $2.02B | $265.81M | $103.52M | $77.84M | $0.58 | 20.62% | 369.11% | N/A | N/A | 2026-03-04 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.15B | $825.94M | $269.64M | $185.68M | $3.23 | 21.13% | 49.81% | 50.23% | N/A | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.85B | $578.20M | $323.88M | $217.56M | $1.79 | 25.56% | 37.37% | 43.20% | 21.00% | |||
| MDXG | MIMEDX GROUP INC | $959.70M | $393.44M | $69.21M | $40.83M | $0.28 | 14.77% | 8.97% | -55.56% | N/A | |||
| INVA | INNOVIVA INC | $1.49B | $388.52M | $214.76M | $127.34M | $1.89 | 10.14% | 3.81% | 87.13% | -2.45% | 2026-03-04 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $81.59B | $14.25B | $5.71B | $4.58B | $43.45 | 2.89% | 12.41% | 0.49% | 8.33% | 2026-01-30 | ||
| UTHR | UNITED THERAPEUTICS CORP | $21.39B | $3.13B | $1.77B | $1.27B | $28.48 | 13.50% | 17.29% | 17.15% | 21.79% | 2026-02-25 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $4.45B | $1.05B | $287.72M | $261.17M | $1.57 | 12.69% | 20.10% | 101.28% | N/A | |||
| INCY | INCYTE CORP | $19.91B | $4.81B | $1.68B | $1.19B | $6.04 | 18.09% | 14.40% | 3,452.94% | N/A | 2026-02-18 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.